Multimodality management of Spetzler-Martin Grade III arteriovenous malformations

Area of Science:

• Neurology
• Neurosurgery
• Vascular Malformations

Background:

• Grade III arteriovenous malformations (AVMs) present diverse challenges due to variations in size, location within eloquent cortex, and central venous drainage.
• These morphological characteristics significantly influence management strategies and patient outcomes.

Purpose of the Study:

• To evaluate the impact of size, eloquent cortex location, and central venous drainage on the outcomes of Grade III AVMs.
• To determine if Spetzler-Martin grading characteristics correlate with neurological deficits and obliteration rates.

Main Methods:

• Retrospective analysis of 100 patients treated for Grade III AVMs between 1984 and 2010.
• AVMs categorized by Spetzler-Martin characteristics (Type 1-4) based on size, eloquence, and venous drainage.
• Correlation of treatment outcomes (neurological deficit, functional status, obliteration) with demographic and morphological factors.

Main Results:

• Multimodality treatment (embolization, surgery, radiosurgery) achieved a 1% mortality rate and 87.6% obliteration rate.
• New neurological deficits occurred in 14% of patients, with disabling deficits in 5%.
• Smaller AVMs (<3 cm) showed significantly better outcomes regarding new neurological deficits compared to larger AVMs (p < 0.002). Older age and nonhemorrhagic presentation also predicted deficits.

Conclusions:

• Multimodality management of Grade III AVMs yields high obliteration rates irrespective of size, venous drainage, or eloquent location.
• AVM size is a critical factor predicting the risk of new neurological deficits.
• Subclassifying Grade III AVMs by size (<3 cm vs. ≥3 cm) is proposed to better stratify treatment risks.